LifeMD: 3 Key Takeaways for Long-Term Investors
LifeMD announced strategic shifts including direct pharmacy partnerships with Eli Lilly and Novo Nordisk for GLP-1 medications, a major enterprise collaboration with AT&T providing access to 100 million customers, and lower introductory pricing that increased multi-month subscriptions from 25% to 85%. The company expects flat overhead while patient volume grows, positioning it well in the virtual care and pharmacy market.